Safety and angiography data of amediplase, a new fibrin thrombolytic agant, given as a bolus to patients with acute myocardial infarction: the 2K2 dose finding trial - Vermeer, F; Pohl, J; Oldroyd, K (J Am Coll Cardiol, 2001)
(Suppl A):